“Attenuated” Pulmonary Tumor Thrombotic Microangiopathy on Anti-Vascular Endothelial Growth Factor Treatment: A Case Report

VEGF inhibitors may attenuate PTTM symptoms. Even with mild respiratory symptoms, oncologists should consider PTTM in patients with cancer on VEGF inhibitors.

Authors

Institutions

Publication Details

Journal
Case Reports in Oncology
Published
2025-05-14
DOI
https://doi.org/10.1159/000543930
Primary Topic
Cardiac tumors and thrombi
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

“Attenuated” Pulmonary Tumor Thrombotic Microangiopathy on Anti-Vascular Endothelial Growth Factor Treatment: A Case Report

Koichi Suyama, Yuji Miura, Yuko Tanabe, Rika Kizawa et al.
Case Reports in Oncology
Cardiac tumors and thrombi
article

“Attenuated” Pulmonary Tumor Thrombotic Microangiopathy on Anti-Vascular Endothelial Growth Factor Treatment: A Case Report

Koichi Suyama, Yuji Miura, Yuko Tanabe, Rika Kizawa, Haruka Ozaki, Takeshi Yamaguchi
article en

Abstract

VEGF inhibitors may attenuate PTTM symptoms. Even with mild respiratory symptoms, oncologists should consider PTTM in patients with cancer on VEGF inhibitors.

Case Reports in OncologyVol. 18(1)
Toranomon Hospital (JP)
Openalex Percentile: Top 81%
Cardiac tumors and thrombi
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.